6.690NOK+5.02%Mkt Cap: 225.13M $P/E: —Today
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 200…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
| Headline | Source | Time |
|---|---|---|
This week | ||
Older | ||
Thor Medical ASA (STU:8NN) Full Year 2025 Earnings Call Highlights: Strategic Growth Amid ... Thor Medical ASA (STU:8NN) outlines its path to profitability with a robust order backlog and strategic funding, despite current financial losses. | ||
IInvestornytt | ||
Thor Medical ASA (FRA:8NN) (Half Year 2025) Earnings Call Highlights: Navigating Growth and ... Thor Medical ASA (FRA:8NN) showcases strategic advancements and financial hurdles as it aims for market leadership in alpha-emitting isotopes. | ||
TTeknisk Ukeblad | ||